Advertisement

Topics

GSK Moves Closer To Priority Review Voucher As US Panel Backs Malaria Drug Tafenoquine

17:37 EDT 12 Jul 2018 | SCRIP

GlaxoSmithKline's user fee date is July 22, four days before advisory committee review of 60 Degrees’ separate application for the...

      

Related Stories

 

Original Article: GSK Moves Closer To Priority Review Voucher As US Panel Backs Malaria Drug Tafenoquine

NEXT ARTICLE

More From BioPortfolio on "GSK Moves Closer To Priority Review Voucher As US Panel Backs Malaria Drug Tafenoquine"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...